Human NRG1-alpha/HRG1-alpha quantitates human NRG1-alpha/HRG1-alpha in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human NRG1-alpha/HRG1-alpha.
Human NRG1-alpha/HRG1-alpha quantitates human NRG1-alpha/HRG1-alpha in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human NRG1-alpha/HRG1-alpha.
Neureguline 1 (NRG1) was initially identified as a 44 kD glycoprotein interacting with the tyrosine kinase of the NEU/ERBB2 receptor to increase its phosphorylation on tyrosine residues. It is known that an extraordinary variety of different isoforms is produced from the NRG1 gene by alternative splicing. These isoforms include heregulins (HRG), glial growth factors (GGF) and sensory and motor neuron (SMDF) derived factor. They are specifically expressed in tissues and differ considerably in their structure. The HRG isoforms all contain domains similar to the epidermal growth factor (EGF) and l-immunoglobulin (Ig). The GGF and GGF2 isoforms contain a kringle-like sequence plus domains similar to l-Ig and the EGF; the SMDF isoform only shares the domain similar to the EGF with other isoforms. The receptors of all NRG1 isoforms are the ERBB family of tyrosine kinase transmembrane receptors. Through interaction with ERBB receptors, NRG1 isoforms induce growth and differentiation of epithelial, neuronal, glial and other cells.
Sensitivity
Sensitivity of the dosage: 12 pg/ml.
Measurement range
Dose range: 12.29 to 3.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17195119 |
| Specifications |
| Accession number | 6030402G23Rik; activity inducing acetylcholine receptors; ARIA; differentiation factor of breast cancer cells p45; D230005F13Rik; GGF; GGF2; GGFII; glial growth factor; glial growth factor 2; hereguline; hereguline, alpha (45 kD, ERB activator) |
| Dose range | 12.29 to 3.000 pg/ml |
| Sensitivity of the dosage | 12 pg/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | Q02297 |
| Gene symbol(s) | NRG1 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | NRG1 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Supernatant, 50 µl; serum, 50 µl; plasma, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH349RBX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.